id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2021-0006-0003,DEA,DEA-2021-0006,Signed OASH Letter to DEA with Review 02Jul20,Supporting & Related Material,,2021-03-09T05:00:00Z,2021,3,,,2021-03-09T14:01:14Z,,0,0,0900006484a64123
DEA-2021-0006-0002,DEA,DEA-2021-0006,DEA Eight-Factor Analysis for 10 FRS,Supporting & Related Material,,2021-03-09T05:00:00Z,2021,3,,,2021-03-09T14:01:02Z,,0,0,0900006484a64120
DEA-2021-0006-0001,DEA,DEA-2021-0006,Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2021-03-03T05:00:00Z,2021,3,2021-03-03T05:00:00Z,2021-04-03T03:59:59Z,2021-04-02T01:00:56Z,2021-04214,0,0,0900006484a5c7c4